Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26F1FYH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,041
Award facts
- Contract value 100% obligated
- $8,040.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,040.58 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, which was competitively awarded without set-aside provisions, has a performance completion date of December 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
The OmniPod 5 pods represent a critical medical supply component within AmerisourceBergen's extensive portfolio of pharmaceutical and medical device products delivered to federal healthcare systems. The company supplies the Defense Health Agency, U.S. Coast Guard, and other military healthcare organizations through its prime vendor vehicle, which encompasses specialty medications, vaccines, medical devices, and related supplies across multiple therapeutic domains. This particular delivery order supports the ongoing diabetes management requirements of federal military and healthcare beneficiaries through continuous glucose monitoring and insulin infusion technology.
Quick answers
Who was awarded contract SPE2DR26F1FYH?
SPE2DR26F1FYH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F1FYH worth?
The government has obligated $8,041 on SPE2DR26F1FYH.
Is contract SPE2DR26F1FYH an order under another contract?
Yes. SPE2DR26F1FYH is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1FYH competed?
The extent of competition for SPE2DR26F1FYH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award